Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis

Journal of General Virology

Volumn 97, Issue 12, 2016, Pages 3302-3312

  Naciute, Milda ^a   Mieliauskaite, Diana ^a   Rugiene, Rita ^a,b   Nikitenkiene, Rita ^a   Jancoriene, Ligita ^b   Mauricas, Mykolas ^a   Nora Krukle, Zaiga ^c   Murovska, Modra ^c   Girkontaite, Irute ^a  

^a State Research Institute Centre for Innovative Medicine   (Lithuania)

^b VILNIUS UNIVERSITY   (Lithuania)

^c RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

Antibodies; IL 6; Parvovirus B19; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PROTEIN VP1; PROTEIN VP2; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR; VIRUS DNA;

ADULT; ARTICLE; BLOOD; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARVOVIRUS INFECTION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VIRUS DETECTION; AGED; CASE CONTROL STUDY; GENETICS; ISOLATION AND PURIFICATION; PHYSIOLOGY; VIROLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 85007223349     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000621     Document Type: Article

References (73)

1. Arabski, M., Fudala, R., Koza, A., Wasik, S., Futoma-Koloch, B., BuglaPloskonska, G. & Kaca, W. (2012). The presence of anti-LPS antibodies and human serum activity against Proteus mirabilis S/R forms in correlation with TLR4 (Thr399Ile) gene polymorphism in rheumatoid arthritis. Clin Biochem 45, 1374-1382.
2. Arleevskaya, M. I., Gabdoulkhakova, A. G., Filina, Y. V., Miftakhova, R. R., Bredberg, A. & Tsybulkin, A. P. (2014). A transient peak of infections during onset of rheumatoid arthritis: a 10-year prospective cohort study. BMJ Open 4: e005254.
3. Azzi, A., Manaresi, E., Zakrzewska, K., DeSantis, R., Musiani, M. & Zerbini, M. (2004). Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. J Med Virol 72, 679-682
4. Bartold, P. M., Marino, V., Cantley, M. & Haynes, D. R. (2010). Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol 37, 405-411.
5. Berry, P. J., Gray, E. S., Porter, H. J. & Burton, P. A. (1992). Parvovirus infection of the human fetus and newborn. Semin Diagn Pathol 9, 4-12.
6. Bertoni, E., Rosati, A., Zanazzi, M., Azzi, A., Zakrzewska, K., Guidi, S., Fanci, R. & Salvadori, M. (1997). Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. J Nephrol 10, 152-156.
7. Bratslavska, O., Kozireva, S., Baryshev, M., Russev, R., Alexandrov, M., Uzameckis, D., Todorova, K., Dimitrov, P. & Murovska, M. (2015). Parvovirus B19 infection increases proliferative activity of non-permissive cells. Virologie 68, 49-58.
8. Brown, T., Anand, A., Ritchie, L. D., Clewley, J. P. & Reid, T. M. (1984). Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 2, 1033-1034.
9. Caliskan, R., Masatlioglu, S., Aslan, M., Altun, S., Saribas, S., Ergin, S., Uckan, E., Koksal, V., Oz, V. & other authors (2005). The relationship between arthritis and human parvovirus B19 infection. Rheumatol Int 26, 7-11.
10. Chapenko, S., Krumina, A., Logina, I., Rasa, S., Chistjakovs, M., Sultanova, A., Viksna, L. & Murovska, M. (2012). Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv Virol 2012, 205085.
11. Chen, Y. S., Chou, P. H., Li, S. N., Tsai, W. C., Lin, K. H., Tsai, K. B., Yen, J. H. & Liu, H. W. (2006). Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan. J Rheumatol 33, 887-891.
12. Chorba, T., Coccia, P., Holman, R. C., Tattersall, P., Anderson, L. J., Sudman, J., Young, N. S., Kurczynski, E., Saarinen, U. M. & other authors (1986). The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 154, 383-393.
13. Clewley, J. P., Cohen, B. J. & Field, A. M. (1987). Detection of parvovirus B19 DNA, antigen, and particles in the human fetus. J Med Virol 23, 367-376.
14. Cohen, B. J., Beard, S., Knowles, W. A., Ellis, J. S., Joske, D., Goldman, J. M., Hewitt, P. & Ward, K. N. (1997). Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 37, 947-952.
15. Corcoran, A., Doyle, S., Waldron, D., Nicholson, A. & Mahon, B. P. (2000). Impaired gamma interferon responses against parvovirus B19 by recently infected children. J Virol 74, 9903-9910.
16. Cotmore, S. F., McKie, V. C., Anderson, L. J., Astell, C. R. & Tattersall, P. (1986). Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60, 548-557.
17. De Re, V., De Vita, S., Battistella, V., Marzotto, A., Libra, M., Ferraccioli, G. & Boiocchi, M. (2002). Absence of human parvovirus B19 DNA in myoepithelial sialadenitis of primary Sjögren’s syndrome. Ann Rheum Dis 61, 855-856.
18. De Stefano, R., Manganelli, S., Frati, E., Selvi, E., Azzi, A., Zakrzewska, K. & Marcolongo, R. (2003). No association between human parvovirus B19 infection and Sjögren’s syndrome. Ann Rheum Dis 62, 86-87.
19. Dijkmans, B. A., van Elsacker-Niele, A. M., Salimans, M. M., van Albada-Kuipers, G. A., de Vries, E. & Weiland, H. T. (1988). Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum 31, 279-281.
20. Durigon, E. L., Erdman, D. D., Gary, G. W., Pallansch, M. A., Torok, T. J. & Anderson, L. J. (1993). Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods 44, 155-165.
21. Heegaard, E. D. & Laub Petersen, B. (2000). Parvovirus B19 transmitted by bone marrow. Br J Haematol 111, 659-661.
22. Hitchon, C. A., Chandad, F., Ferucci, E. D., Willemze, A., IoanFacsinay, A., van der Woude, D., Markland, J., Robinson, D., Elias, B. & other authors (2010). Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 37, 1105-1112.
23. Hsu, T. C. & Tsay, G. J. (2001). Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology 40, 152-157.
24. Hsu, T. C., Tzang, B. S., Huang, C. N., Lee, Y. J., Liu, G. Y., Chen, M. C. & Tsay, G. J. (2006). Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells. Clin Exp Immunol 144, 152-157.
25. Juhl, D., Steppat, D., Görg, S. & Hennig, H. (2014). Parvovirus b19 infections and blood counts in blood donors. Transfus Med Hemother 41, 52-59
26. Kakurina, N., Kadisa, A., Lejnieks, A., Mikazane, H., Kozireva, S. & Murovska, M. (2015). Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19. Medicina 51, 18-24.
27. Kerr, J. R. (2000). Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 59, 672-683.
28. Kerr, J. R., Cartron, J. P., Curran, M. D., Moore, J. E., Elliott, J. R. & Mollan, R. A. (1995). A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 34, 809-813.
29. Kerr, J. R., Barah, F., Mattey, D. L., Laing, I., Hopkins, S. J., Hutchinson, I. V. & Tyrrell, D. A. (2001). Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol 82, 3011-3019.
30. Kerr, J. R., Cunniffe, V. S., Kelleher, P., Coats, A. J. & Mattey, D. L. (2004). Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 74, 147-155.
31. Kinney, J. S., Anderson, L. J., Farrar, J., Strikas, R. A., Kumar, M. L., Kliegman, R. M., Sever, J. L., Hurwitz, E. S. & Sikes, R. K. (1988). Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 157, 663-667.
32. Kozireva, S. V., Zestkova, J. V., Mikazane, H. J., Kadisa, A. L., Kakurina, N. A., Lejnieks, A. A., Danilane, I. N. & Murovska, M. F. (2008). Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. J Rheumatol 35, 1265-1270.
33. Kurtzman, G. J., Cohen, B. J., Field, A. M., Oseas, R., Blaese, R. M. & Young, N. S. (1989). Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84, 1114-1123.
34. Lefrere, J. J., Courouce, A. M., Bertrand, Y., Girot, R. & Soulier, J. P. (1986). Human parvovirus and aplastic crisis in chronic hemolytic anemias: a study of 24 observations. Am J Hematol 23, 271-275.
35. Lehmann, H. W., Lutterbüse, N., Plentz, A., Akkurt, I., Albers, N., Hauffa, B. P., Hiort, O., Schoenau, E. & Modrow, S. (2008). Association of parvovirus B19 infection and Hashimoto’s thyroiditis in children. Viral Immunol 21, 379-383.
36. Leisi, R., Ruprecht, N., Kempf, C. & Ros, C. (2013). Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism. J Virol 87, 13161-13167.
37. Lui, S. L., Luk, W. K., Cheung, C. Y., Chan, T. M., Lai, K. N. & Peiris, J. S. (2001). Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 71, 59-64.
38. Magnusson, M., Brisslert, M., Zendjanchi, K., Lindh, M. & Bokarewa, M. I. (2010). Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment. Rheumatology 49, 1911-1919.
39. Manaresi, E., Gallinella, G., Zerbini, M., Venturoli, S., Gentilomi, G. & Musiani, M. (1999). IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay. J Med Virol 57, 174-178.
40. Manaresi, E., Gallinella, G., Venturoli, S., Zerbini, M. & Musiani, M. (2004). Detection of parvovirus B19 IgG: choice of antigens and serological tests. J Clin Virol 29, 51-53.
41. Manicourt, D. H., Triki, R., Fukuda, K., Devogelaer, J. P., Nagant de Deuxchaisnes, C. & Thonar, E. J. (1993). Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 36, 490-499.
42. McInnes, I. B. & Schett, G. (2011). The pathogenesis of rheumatoid arthritis. N Engl J Med 365, 2205-2219.
43. Meron, M. K., Amital, H., Shepshelovich, D., Barzilai, O., Ram, M., Anaya, J. M., Gerli, R., Bizzaro, N., Nicola, B. & Shoenfeld, Y. (2010). Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol 38, 287-291.
44. Milla, F., Feliu, E., Ribera, J. M., Junca, J., Flores, A., Vidal, J., Zarco, M. A. & Masat, T. (1993). Electron microscopic identification of parvovirus virions in erythroid and granulocytic-line cells in a patient with human parvovirus B19 induced pancytopenia. Leuk Lymphoma 10, 483-487.
45. Moore, T. L., Bandlamudi, R., Alam, S. M. & Nesher, G. (1999). Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin Arthritis Rheum 28, 314-318.
46. Morey, A. L. & Fleming, K. A. (1992). Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro. Br J Haematol 82, 302-309.
47. Mourgues, C., Henquell, C., Tatar, Z., Pereira, B., Nourisson, C., Tournadre, A., Soubrier, M. & Couderc, M. (2016). Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis. Joint Bone Spine 83, 412-415.
48. Musiani, M., Pasini, P., Zerbini, M., Gentilomi, G., Roda, A., Gallinella, G., Manaresi, E. & Venturoli, S. (1999). Prenatal diagnosis of parvovirus B19-induced hydrops fetalis by chemiluminescence in situ hybridization. J Clin Microbiol 37, 2326-2329.
49. Nikkari, S., Roivainen, A., Hannonen, P., Möttönen, T., Luukkainen, R., Yli-Jama, T. & Toivanen, P. (1995). Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 54, 597-600.
50. Oguz, F., Akdeniz, C., Unüvar, E., Küçükbasmaci, O. & Sidal, M. (2002). Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health 38, 358-362.
51. Okada, Y., Kim, K., Han, B., Pillai, N. E., Ong, R. T., Saw, W. Y., Luo, M., Jiang, L., Yin, J. & other authors (2014). Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet 23, 6916-6926.
52. Ozawa, K. & Young, N. (1987). Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol 61, 2627-2630.
53. Ozawa, K., Ayub, J., Hao, Y. S., Kurtzman, G., Shimada, T. & Young, N. (1987). Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 61, 2395-2406.
54. Pfrepper, K. I., Enders, M. & Motz, M. (2005). Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J Vet Med B Infect Dis Vet Public Health 52, 362-365.
55. Ramos-Casals, M., Cervera, R., García-Carrasco, M., Vidal, J., Trejo, O., Jimenez, S., Costa, J., Font, J. & Ingelmo, M. (2000). Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren’s syndrome. Semin Arthritis Rheum 29, 373-378.
56. Reid, D. M., Reid, T. M., Brown, T., Rennie, J. A. & Eastmond, C. J. (1985). Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1, 422-425.
57. Saikawa, T., Anderson, S., Momoeda, M., Kajigaya, S. & Young, N. S. (1993). Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 67, 3004-3009.
58. Sato, H., Hirata, J., Kuroda, N., Shiraki, H., Maeda, Y. & Okochi, K. (1991). Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies. J Virol 65, 5485-5490.
59. Scott, D. L., Wolfe, F. & Huizinga, T. W. (2010). Rheumatoid arthritis. Lancet 376, 1094-1108.
60. Seve, P., Ferry, T., Koenig, M., Cathebras, P., Rousset, H. & Broussolle, C. (2005). Lupus-like presentation of parvovirus B19 infection. Semin Arthritis Rheum 34, 642-648.
61. Shimamoto, K., Ito, T., Ozaki, Y., Amuro, H., Tanaka, A., Nishizawa, T., Son, Y., Inaba, M. & Nomura, S. (2013). Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. J Rheumatol 40, 1074-1081
62. Söderlund, M., Brown, C. S., Spaan, W. J., Hedman, L. & Hedman, K. (1995). Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 172, 1431-1436.
63. Söderlund, M., von Essen, R., Haapasaari, J., Kiistala, U., Kiviluoto, O. & Hedman, K. (1997). Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349, 1063-1065.
64. Söderlund-Venermo, M., Hokynar, K., Nieminen, J., Rautakorpi, H. & Hedman, K. (2002). Persistence of human parvovirus B19 in human tissues. Pathol Biol 50, 307-316.
65. Stabler, T., Piette, J. C., Chevalier, X., Marini-Portugal, A. & Kraus, V. B. (2004). Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 50, 3663-3667
66. Takahashi, Y., Murai, C., Shibata, S., Munakata, Y., Ishii, T., Ishii, K., Saitoh, T., Sawai, T., Sugamura, K. & Sasaki, T. (1998). Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U SA 95, 8227-8232.
67. Tzang, B. S., Chiu, C. C., Tsai, C. C., Lee, Y. J., Lu, I. J., Shi, J. Y. & Hsu, T. C. (2009a). Effects of human parvovirus B19 VP1 unique region protein on macrophage responses. J Biomed Sci 16, 13.
68. Tzang, B. S., Tsai, C. C., Tsay, G. J., Wang, M., Sun, Y. S. & Hsu, T. C. (2009b). Anti-human parvovirus B19 nonstructural protein antibodies in patients with rheumatoid arthritis. Clin Chim Acta 405, 76-82.
69. Voll, R. E., Roth, E. A., Girkontaite, I., Fehr, H., Herrmann, M., Lorenz, H. M. & Kalden, J. R. (1997). Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce doublestranded DNA antibody production. Arthritis Rheum 40, 2162-2171.
70. von Poblotzki, A., Gigler, A., Lang, B., Wolf, H. & Modrow, S. (1995). Antibodies to parvovirus B19 NS-1 protein in infected individuals. J Gen Virol 76, 519-527.
71. Wang, J., Zhang, W., Liu, H., Wang, D., Wang, W., Li, Y., Wang, Z., Wang, L., Zhang, W. & Huang, G. (2010). Parvovirus B19 infection associated with Hashimoto’s thyroiditis in adults. J Infect 60, 360-370.
72. White, D. G., Woolf, A. D., Mortimer, P. P., Cohen, B. J., Blake, D. R. & Bacon, P. A. (1985). Human parvovirus arthropathy. Lancet 1, 419-421
73. Zuffi, E., Manaresi, E., Gallinella, G., Gentilomi, G. A., Venturoli, S., Zerbini, M. & Musiani, M. (2001). Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans. Viral Immunol 14, 151-158